E. Im

发表

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding

J. Gatell, H. McShane, Denise Teoh, 2007, Journal of Virology.

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of HIV-1 through Breastfeeding

J. Gatell, H. McShane, Denise Teoh, 2007 .

Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination

D. Irvine, Heikyung Suh, Jamal Elkhader, 2013, Science Translational Medicine.

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

S. Soneji, J. Sadoff, T. Hanke, 2010, Journal of Virology.

Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa

A. McMichael, T. Hanke, N. Chen, 2004, Gene Therapy.

Safety and Immunogenicity of Novel Recombinant BCG and Modiﬁed Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques (cid:1)

S. Soneji, J. Sadoff, T. Hanke, 2010 .

Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus Challenges

A. McMichael, Y. Roshorm, D. Volsky, 2011, PLoS pathogens.

Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine

Bette Korber, Tao Dong, Lucy Dorrell, 2007, PloS one.

Long peptides induce polyfunctional T cells against conserved regions of HIV‐1 with superior breadth to single‐gene vaccines in macaques

A. Nicosia, C. Melief, A. McMichael, 2010, European journal of immunology.

Combined single‐clade candidate HIV‐1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference

A. McMichael, C. Williamson, R. Wagner, 2007, European journal of immunology.

Newborn Mice Vaccination with BCG.HIVA222 + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes

J. Gatell, T. Hanke, N. Saubí, 2011, Clinical & developmental immunology.

MVA as a vector for vaccines against HIV-1

T. Hanke, E. Im, 2004, Expert review of vaccines.

Recombination–deletion between homologous cassettes in retrovirus is suppressed via a strategy of degenerate codon substitution

R. Junghans, A. Bais, Xiuyang Guo, 2014, Molecular therapy. Methods & clinical development.

Short communication: preclinical evaluation of candidate HIV type 1 vaccines in inbred strains and an outbred stock of mice.

T. Hanke, E. Im, 2007, AIDS research and human retroviruses.

Correction: Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine

B. Korber, A. McMichael, T. Hanke, 2011, PLoS ONE.

Induction of long‐lasting multi‐specific CD8+ T cells by a four‐component DNA‐MVA/HIVA‐RENTA candidate HIV‐1 vaccine in rhesus macaques

A. McMichael, T. Hanke, J. Nkolola, 2006, European Journal of Immunology.

Design and Pre-Clinical Evaluation of a Universal HIV-1

B. Korber, A. McMichael, T. Hanke, 2007 .

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

J. Gatell, T. Hanke, N. Saubí, 2009, Retrovirology.

Long peptides induce polyfunctional T cells against conserved regions of HIV‐1 with superior breadth to single‐gene vaccines in macaques

A. Nicosia, C. Melief, A. McMichael, 2010, European journal of immunology.

Development of a Universal T Cell Vaccine

B. Korber, A. McMichael, T. Hanke, 2008 .

Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination

D. Irvine, Heikyung Suh, Jamal Elkhader, 2013, Science Translational Medicine.

An Attenuated Listeria monocytogenes Vector Primes More Potent Simian Immunodeficiency Virus-Specific Mucosal Immunity than DNA Vaccines in Mice

D. Barouch, N. Provine, E. Borducchi, 2013, Journal of Virology.